- Home
- IMMX vs MESA Comparison
IMMX vs MESA Comparison
Compare IMMX & MESA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- MESA
- Stock Information
- Founded
- IMMX 2014
- MESA 1982
- Country
- IMMX United States
- MESA United States
- Employees
- IMMX N/A
- MESA N/A
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- MESA Air Freight/Delivery Services
- Sector
- IMMX Health Care
- MESA Consumer Discretionary
- Exchange
- IMMX Nasdaq
- MESA Nasdaq
- Market Cap
- IMMX 61.1M
- MESA 42.2M
- IPO Year
- IMMX 2021
- MESA 2018
- Fundamental
- Price
- IMMX $2.76
- MESA $1.05
- Analyst Decision
- IMMX Strong Buy
- MESA
- Analyst Count
- IMMX 1
- MESA 0
- Target Price
- IMMX $7.00
- MESA N/A
- AVG Volume (30 Days)
- IMMX 147.9K
- MESA 130.3K
- Earning Date
- IMMX 08-11-2025
- MESA 08-15-2025
- Dividend Yield
- IMMX N/A
- MESA N/A
- EPS Growth
- IMMX N/A
- MESA N/A
- EPS
- IMMX N/A
- MESA N/A
- Revenue
- IMMX N/A
- MESA $424,030,000.00
- Revenue This Year
- IMMX N/A
- MESA $39.81
- Revenue Next Year
- IMMX N/A
- MESA N/A
- P/E Ratio
- IMMX N/A
- MESA N/A
- Revenue Growth
- IMMX N/A
- MESA N/A
- 52 Week Low
- IMMX $1.26
- MESA $0.68
- 52 Week High
- IMMX $3.09
- MESA $1.89
- Technical
- Relative Strength Index (RSI)
- IMMX 61.86
- MESA 65.71
- Support Level
- IMMX $2.61
- MESA $0.91
- Resistance Level
- IMMX $2.80
- MESA $0.97
- Average True Range (ATR)
- IMMX 0.18
- MESA 0.03
- MACD
- IMMX 0.04
- MESA 0.02
- Stochastic Oscillator
- IMMX 68.60
- MESA 100.00
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About MESA Mesa Air Group Inc.
Mesa Air Group Inc is a regional air carrier providing scheduled passenger service. It provides services to the District of Columbia, Canada, Cuba, and Mexico, and cargo services out of Cincinnati/Northern Kentucky International Airport. Flights are operated as American Eagle, United Express, or DHL Express flights to the terms of capacity purchase agreements with American and United and a flight services agreement with DHL. The business has a presence in domestic hubs and cities, including Dallas, Houston, Phoenix, and Washington-Dulles, and other regions.